These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21775166)

  • 21. Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial.
    Weir MR; Yeh F; Silverman A; Devereux RB; Galloway JM; Henderson JA; Howard WJ; Russell M; Wilson C; Ratner R; Sorkin J; Umans JG; Fleg JL; Stylianou M; Lee E; Howard BV
    J Clin Hypertens (Greenwich); 2009 Oct; 11(10):540-8. PubMed ID: 19817934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.
    Bertoni AG; Clark JM; Feeney P; Yanovski SZ; Bantle J; Montgomery B; Safford MM; Herman WH; Haffner S;
    J Diabetes Complications; 2008; 22(1):1-9. PubMed ID: 18191071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
    Wens J; Gerard R; Vandenberghe H
    Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
    Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
    Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Differences between management guidelines and global health strategies for arterial hypertension with metabolic disorders in France in 1999. Ohara study].
    Mallion JM; Kahn JC; Poncelet P; Pannier B; Vaïsse B; Koch C; Phan TM; Pithois-Merli I
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):834-8. PubMed ID: 11575213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
    Bays HE
    Endocr Pract; 2011; 17(6):933-8. PubMed ID: 21856592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
    Handelsman Y; Goldberg RB; Garvey WT; Fonseca VA; Rosenstock J; Jones MR; Lai YL; Jin X; Misir S; Nagendran S; Abby SL
    Endocr Pract; 2010; 16(4):617-28. PubMed ID: 20634176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triglyceride to high-density lipoprotein cholesterol ratio and carotid intima-medial thickness in Chinese adolescents with newly diagnosed type 2 diabetes mellitus.
    Li X; Deng YP; Yang M; Wu YW; Sun SX; Sun JZ
    Pediatr Diabetes; 2016 Mar; 17(2):87-92. PubMed ID: 25582650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index <35 kg/m2.
    Serrot FJ; Dorman RB; Miller CJ; Slusarek B; Sampson B; Sick BT; Leslie DB; Buchwald H; Ikramuddin S
    Surgery; 2011 Oct; 150(4):684-91. PubMed ID: 22000180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
    Rosenstock J; Fonseca VA; Garvey WT; Goldberg RB; Handelsman Y; Abby SL; Lai YL; Jin X; Misir S; Nagendran S; Jones MR
    Endocr Pract; 2010; 16(4):629-40. PubMed ID: 20634175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of exenatide on metabolic parameters/control in obese Japanese patients with type 2 diabetes.
    Tokuda M; Katsuno T; Ochi F; Miyakoshi K; Kusunoki Y; Murai K; Miuchi M; Hamaguchi T; Miyagawa J; Namba M
    Endocr J; 2014; 61(4):365-72. PubMed ID: 24452017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
    Jialal I; Abby SL; Misir S; Nagendran S
    Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensive lipid-lowering therapy for slowing progression as well as inducing regression of atherosclerosis in Japanese patients: subanalysis of the JART study.
    Yamazaki T; Nohara R; Daida H; Hata M; Kaku K; Kawamori R; Kishimoto J; Kurabayashi M; Masuda I; Sakuma I; Yokoi H; Yoshida M;
    Int Heart J; 2013; 54(1):33-9. PubMed ID: 23428922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired systolic blood dipping and nocturnal hypertension: an independent predictor of carotid intima-media thickness in type 1 diabetic patients.
    Atabek ME; Akyürek N; Eklioglu BS; Alp H
    J Diabetes Complications; 2014; 28(1):51-5. PubMed ID: 24157221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metabolic control and weight loss in patients with obesity and type 2 diabetes mellitus, treated with exenatide].
    Pujante Alarcón P; Hellín Gil MD; Román LM; Ferrer Gómez M; García Zafra MV; Tébar Massó J
    Med Clin (Barc); 2012 Dec; 139(13):572-8. PubMed ID: 22209597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality measure attainment in patients with type 2 diabetes mellitus.
    Lafeuille MH; Grittner AM; Gravel J; Bailey RA; Martin S; Garber L; Sheng Duh M; Lefebvre P
    Am J Manag Care; 2014 Jan; 20(1 Suppl):s5-15. PubMed ID: 24512194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different effects of antihypertensive regimens based on fosinopril or hydrochlorothiazide with or without lipid lowering by pravastatin on progression of asymptomatic carotid atherosclerosis: principal results of PHYLLIS--a randomized double-blind trial.
    Zanchetti A; Crepaldi G; Bond MG; Gallus G; Veglia F; Mancia G; Ventura A; Baggio G; Sampieri L; Rubba P; Sperti G; Magni A;
    Stroke; 2004 Dec; 35(12):2807-12. PubMed ID: 15514192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.
    Bots ML; Palmer MK; Dogan S; Plantinga Y; Raichlen JS; Evans GW; O'Leary DH; Grobbee DE; Crouse JR;
    J Intern Med; 2009 Jun; 265(6):698-707. PubMed ID: 19298496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.